跳至主要内容
临床试验/NCT04240262
NCT04240262招募中不适用

Prospective Observational Trial of Microwave Ablation for Leiomyoma (MYOMIC2)

Karolinska Institutet1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2020年1月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
1
主要终点
Symptom severity of uterine fibroids

研究概览

简要总结

This prospective observational study aims to evaluate the effectiveness and acceptability of percutaneous or vaginal ultrasound guided microwave ablation for the treatment of symptoms related to uterine fibroids. We will include 200 women.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
25 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • premenopausal
  • no future child wish
  • acceptable risks for general anestesia or sedation
  • willing to comply with protocol

排除标准

  • current or future child wish
  • bleeding disorder with increased risk of bleeding

结局指标

主要结局

Symptom severity of uterine fibroids

时间窗: 6 months post treatment

Score of validated form Uterine Fibroid symptom- Quality of Life questionnaire. minumum 0, maximum 100 where higher scores indicate higher symptom severity

次要结局

  • Quality of Life score(6 months post treatment)
  • acceptability(2 hours post treatment and 6 months post treatment (+/- 2 weeks))
  • menstrual bleeding(6 months post treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Helena Kopp Kallner

Senior consultant ob/gyn

Karolinska Institutet

研究点 (1)

Loading locations...

相似试验